Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.4% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
IDEAYA Biosciences
IDYA
$3.49B
| $1.43M | ﹤0.01% |
60,700
-78,700
| -56% | -$1.52M |
|
2427
Chicago Rivet & Machine Co
CVR
$10M
| $1.42M | ﹤0.01% |
55,810
| – | – |
|
2428
Tenax Therapeutics
TENX
$498M
| $1.42M | ﹤0.01% |
467
+200
| +75% | +$714K |
|
2429
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
| $1.42M | ﹤0.01% |
+13,900
| New | +$1.45M |
|
2430
iShares US Financials ETF
IYF
$4.61B
| $1.42M | ﹤0.01% |
+18,900
| New | +$1.34M |
|
2431
CPS Technologies
CPSH
$84M
| $1.41M | ﹤0.01% |
+107,921
| New | +$1.5M |
|
|
ARAV
2432
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.41M | ﹤0.01% |
214,029
-31,388
| -13% | -$206K |
|
|
BLRX
2433
BioLineRX
BLRX
$12.1M
| $1.41M | ﹤0.01% |
12,628
+5,953
| +89% | +$716K |
|
2434
Flanigan's Enterprises
BDL
$86M
| $1.4M | ﹤0.01% |
59,100
-3,800
| -6% | -$89.8K |
|
|
LUB
2435
DELISTED
Luby's Inc.
LUB
| $1.4M | ﹤0.01% |
424,777
+9,925
| +2% | +$31.2K |
|
2436
DiaMedica Therapeutics
DMAC
$365M
| $1.4M | ﹤0.01% |
153,100
+39,700
| +35% | +$371K |
|
2437
Vanguard International Dividend Appreciation ETF
VIGI
$9.19B
| $1.4M | ﹤0.01% |
+16,900
| New | +$1.41M |
|
2438
cbdMD
YCBD
$5.94M
| $1.4M | ﹤0.01% |
937
+635
| +210% | +$923K |
|
|
ALIM
2439
DELISTED
Alimera Sciences
ALIM
| $1.4M | ﹤0.01% |
145,213
-19,994
| -12% | -$164K |
|
|
CLSD
2440
DELISTED
Clearside Biomedical
CLSD
| $1.39M | ﹤0.01% |
37,633
+7,007
| +23% | +$352K |
|
2441
Kewaunee Scientific
KEQU
$109M
| $1.39M | ﹤0.01% |
112,911
-5,765
| -5% | -$71.9K |
|
2442
Gossamer Bio
GOSS
$87.2M
| $1.39M | ﹤0.01% |
150,000
-32,800
| -18% | -$331K |
|
|
USAP
2443
DELISTED
Universal Stainless & Alloy
USAP
| $1.38M | ﹤0.01% |
136,100
+17,500
| +15% | +$160K |
|
|
MITO
2444
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $1.38M | ﹤0.01% |
881,346
+313,182
| +55% | +$538K |
|
2445
Victory Capital Holdings
VCTR
$6.57B
| $1.38M | ﹤0.01% |
+54,100
| New | +$1.33M |
|
2446
World Kinect Corp
WKC
$1.9B
| $1.38M | ﹤0.01% |
39,300
+15,300
| +64% | +$519K |
|
|
MAGN
2447
Magnera Corp
MAGN
$446M
| $1.38M | ﹤0.01% |
+6,185
| New | +$1.38M |
|
2448
Vishay Intertechnology
VSH
$5.03B
| $1.38M | ﹤0.01% |
57,225
-357,600
| -86% | -$8.37M |
|
2449
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $1.38M | ﹤0.01% |
18,400
+11,500
| +167% | +$837K |
|
|
DVD
2450
DELISTED
Dover Motorsports
DVD
| $1.38M | ﹤0.01% |
667,788
+101,751
| +18% | +$227K |
|
Similar funds
Renaissance Technologies's Q1 2021 Portfolio in Review
As of Q1 2021, Renaissance Technologies held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Renaissance Technologies opened a new position in Paramount Global Class B worth $255M.
- Renaissance Technologies's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Renaissance Technologies added most to Tesla in Q1 2021, an estimated $427M increase.
- Renaissance Technologies's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Renaissance Technologies fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Renaissance Technologies's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Renaissance Technologies opened 591 new positions and closed 676 in Q1 2021.
- Renaissance Technologies's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.